PEComa (TSC2, TFE3): Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 35 year old female who presented with presented with 10 cm mass in her uterus which was thought to be a leiomyoma. Two years from her initial diagnosis, she recurred in the pelvis and subsequently developed lung nodules one year later. After a pathology review, her original diagnosis was revised to metastatic malignant PEComa.

Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim CME, completion, or participation certificates for completing this activity. 

Learning Objectives:

  • Describe the characteristic histologic and immunophenotypic features of PEComas (perivascular epithelioid cell tumors)
  • Analyze the molecular genetic alterations underlying the pathogenesis of PEComas
  • Evaluate the rationale for targeted therapy directed against mTOR for metastatic malignant PEComas

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on January 27, 2019. Participants must complete all necessary course components by this date to receive credit.